GU Ventures portfolio firm OnDosis partners with Adare Pharma Solutions to advance U.S. ADHD program

Bitget2026/10/12 07:58

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

GU Ventures portfolio company OnDosis entered a strategic collaboration with Adare Pharma Solutions to advance its lead U.S. ADHD program.
Deal targets U.S. commercial manufacturing capability, supporting planned bioequivalence studies and a future regulatory filing for Imfocy.
OnDosis develops a handheld Dosage Manager device for individualized oral-drug dosing; GU Ventures remains a shareholder.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GU Ventures AB published the original content used to generate this news brief on October 12, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

GU Ventures portfolio firm OnDosis partners with Adare Pharma Solutions to advance U.S. ADHD program

You may also like

Crypto prices